Metastatic Colon Cancer Terminated Phase 0 Trials for Dasatinib (DB01254)

Also known as: Colon cancer metastatic / Stage IV Colon Cancer / Colon cancer stage IV / Malignant neoplasm of colon stage IV / Colon cancer Duke's D / Malignant neoplasm of colon stage IV, unspecified

IndicationStatusPhase
DBCOND0033231 (Metastatic Colon Cancer)Terminated0
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00835679Cetuximab and/or Dasatinib in Patients With Colorectal Cancer and Liver Metastases That Can Be Removed by SurgeryBasic Science